- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Ulcerative colitis
- Meeting Date: November 2020
- Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 841KB)
- Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 50KB)
Mesalazine – November 2020
Mesalazine: Tablet 1600 mg; Asacol®
Last updated
5 March 2021